vbi-1901
vbi vaccines
['gbm', '$vbiv']
$vbiv [15s. delayed]: issued press release on june 06, 08:00:00: vbi vaccines presents updated phase 2a tumor response and overall survival data for vbi-1901 in recurrent gbm at the 2022 asco annual meeting 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time